Trellus Health plc has entered administration following the appointment of joint administrators Paul Zalkin and Tom Parish of Quantuma Advisory Ltd. The company, which operates through its U.S. subsidiary Trellus Health, Inc., confirmed no returns are anticipated for shareholders in the event of asset sales.
The administrators will pursue a sale of company assets, including shares in Trellus Health, Inc., though specific terms or potential buyers were not disclosed. Singer Capital Markets resigned as the company’s nominated adviser and broker immediately upon the administration announcement.
Under AIM Rule 1, Trellus Health’s ordinary shares will be cancelled from trading on the Alternative Investment Market (AIM) if a replacement nominated adviser is not appointed within six weeks. The company stated it has no current intention of appointing a replacement, indicating an expected delisting by October 5, 2026. Shares remain suspended pending further developments.
The administration follows a prior notification issued on August 21, 2026, though no additional financial or operational context was provided in the announcement.
